Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS

• Status: Completed
• Trial end date: 2017-02-27
• Target enrollment: 0
• Participant gender: All

Summary

This research work is important for the cure/control of HIV infection. The study is intended to confirm the efficacy of "Kallunk Oxide (Immunotherapy)" molecules in the Treatment of HIV infection. The study will investigate the T- Lymphocytes (immune) response to HIV in order to boost the body's natural immune ability against infection. The basic study is directly inhibit a protein's increased functions, not only in the CD4+T cell but also CD3+ and CD8+ T cells and the CD45+. cells.

The 'Yogaprabhava', the drug's effectiveness, and progressive immunity with diet and lifestyle can be more easily studied.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Traditional Alternative Medicine Research, India

Criteria

Inclusion Criteria:

• Clinical diagnosis of HIV/AIDS

• Able to swallow tablets or powder form medicine

• Able to eat nutritional foods

• HIV infected patients

• Signed consent of parent or guardian for patients under 18 years of age

• Interest to use of study drugs

• Follow at a participating clinical site and

• Children greater than 8 years old.

Exclusion Criteria:

• Medical side effects

• Pregnant or breast feedings

• History of significant cardiac abnormalities or dysfunction

• Received certain drugs (Steroid) or treatments

• Unable to followed at a participating clinical center

• Children less than 8 years old

• Any serious conditions (severe chronic stage AIDS cases) at study entry that may affect the results of the study.

• Allergy to any of the study drugs or their formulations

• Tobacco using patients

• Alcohol using patients and

• Drug addicting patients.